ALK inhibitors

From Libre Pathology
Revision as of 23:53, 17 March 2019 by Michael (talk | contribs) (Created page with "'''ALK inhibitors''' are a group of drugs that act on tumours with ALK rearrangements. *Alectinib.<ref name=pmid30790150>{{Cite journal | last1 = Honda | first1 = K. | last2...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

ALK inhibitors are a group of drugs that act on tumours with ALK rearrangements.

See also

References

  1. ↑ Honda, K.; Kadowaki, S.; Kato, K.; Hanai, N.; Hasegawa, Y.; Yatabe, Y.; Muro, K. (Feb 2019). "Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.". Invest New Drugs. doi:10.1007/s10637-019-00742-2. PMID 30790150.
Retrieved from "https://librepathology.org/w/index.php?title=ALK_inhibitors&oldid=49847"